Type 1 Diabetes clinical trials
Showing 51–100 of 210 active trials. Describe your situation to see which ones you may be eligible for.
- Islet Transplantation in Patients With "Brittle" Type I Diabetes
- A Study of GNTI-122 in Adults Recently Diagnosed With T1D
- An Efficacy, Safety, and Tolerability Study of VX-880 in Participants With Type 1 Diabetes With a Kidney Transplant
- The Gut Microbiome in Type 1 Diabetes and Mechanism of Metformin Action
- A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes Mellitus
- Pancreatic Islet Transplantation Into the Anterior Chamber of the Eye
- Effect of Montelukast on Kidney and Vascular Function in Type 1 Diabetes
- Permissive Versus Strict Intrapartum Glucose Management in Type 1 Diabetes (PRISM-T1D)
- Safety, Tolerability, and Efficacy of Immunomodulation With A Monoclonal Antibody Against CD40L in Combination With Transplanted Islet Cells in Adults With Brittle Type 1 Diabetes Mellitus (T1D)
- InvesT1D: Promoting Adolescent Investment in Diabetes Care
- Closed Loop Context Aware AID
- Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus
- MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 Diabetes
- Acetazolamide in Persons With Type 1 Diabetes - Crossover Trial
- Regulation of Brain Glucose Metabolism in Type 1 Diabetes
- Denosumab for Type 1 Diabetes
- Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without Center-Involved Diabetic Macular Edema
- NOURISH - A Healthcare-community Partnership to Improve Nutrition for Optimal Glycemic Control and Pregnancy Outcomes With Pregestational Diabetes
- Pragmatic Clinic-Based Trial of a Mindfulness Based Intervention for Mood Concerns in Youth With Type 1 Diabetes
- Evaluate Use of Tropocells(R) Autologous Platelet-rich Fibrin (PRF) for Wagner Grade 1 and Grade 2, Mild to Mod Neuroischemic Plantar Diabetic Foot Ulcer Wound Care.
- Telemedicine-Delivered Unified Protocol for Cognitive Behavioral Therapy for Anxiety and Depression
- Cardiometabolic Benefit of Reducing Iatrogenic Hyperinsulinemia Using Insulin Adjunctive Therapy in Type 1 Diabetes
- A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
- Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
- Transdisciplinary Care for Young Adults With Type 1 Diabetes
- A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
- Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- A Hybrid Effectiveness-implementation Trial to Reduce Diabetes Distress in Teenagers
- Circadian Mechanisms, Glucose, and CV Risks in T1D
- A Study Comparing Dexcom Continuous Glucose Monitoring to Point of Care Glucose Testing for the Management of Hospital and Post-Discharge Subjects With Type 1 Diabetes
- Monitoring Exhaled Breath to Noninvasively Detect Glycemic Events
- ROME GS System Study
- Accuracy and Precision of the Continuous Glucose Monitoring System 'CareSens Air 3' in Adult Patients With T1DM
- ACCESS 2: AI for pediatriC diabetiC Eye examS Study 2
- Gemini Study: A Prospective, Multicenter Evaluation of Performance and Safety of the Eversense Gemini System With Flash Glucose Measurement Feature
- Continuous Glucose Metrics in Patients With Gastroparesis in Type 1 or Type 2 Diabetes
- Miniaturized Breath-based Sensor for the Detection of Hypo- and Hyperglycemia
- METabolic MODulation to Enhance Insulin Sensitivity and Mitochondrial Function in Type 1 Diabetes (MetMod-T1D)
- Safety and Efficacy of Adjunct Therapies in Adults With Type 1 Diabetes: Multicenter, Registry Study
- Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System
- Skeletal Effects of Type 1 Diabetes on Low-Trauma Fracture Risk
- Long-Term Outcomes of Teplizumab in Routine Clinical Care
- Twiist Postmarket Surveillance Study for Type 1 Diabetes
- A Longitudinal, Observational Study Comparing Real-World Experiences of Teplizumab-Treated and Untreated Participants With Stage 2 Type 1 Diabetes in the United States
- Home-based Oral Glucose Tolerance Test for Type 1 Diabetes Screening
- T1D Pregnancy & Me
- The iLet Experience Study
- HLA Demographics Study in Adults With Type 1 Diabetes
- Monocytes in Subjects With Type 1 Diabetes and Chronic Kidney Disease
- Commercial or Open Source Closed Loop Impact on Pregnancy Study
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.